News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Upstream Biosciences Inc. and McGill University to Collaborate on Testing of Potential Tropical Disease Treatments



7/9/2008 8:30:12 AM

VANCOUVER, BC--(Marketwire - July 09, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced that it has entered into a collaboration with McGill University's Institute of Parasitology in Montreal, Quebec, Canada to begin in vitro testing of the Company's second generation of drug candidates for the potential treatment of tropical diseases leishmaniasis, trypanaosomiasis (African sleeping sickness) and malaria.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES